The Sam Altman biopic is reportedly being circled by Neon and Mubi after Amazon MGM dropped the nearly finished, Andrew ...

Moving forward requires coordinated technical, policy, and educational responses. An outright ban on AI in peer review, as is ...

NPR's Scott Detrow speaks to playwright Kenn Adams about his formula for creating or analyzing stories called the Story Spine.

AI chatbots generate text that is not always The Economist’s cup of tea, but it can rival that of many human writers. Imke ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

APA beat estimated earnings by 44.44%, reporting an EPS of $0.91 versus an estimate of $0.63. Revenue was down $524.00 million from the same period last year. The company beat on EPS by $0.16 in the ...